Synthetic Biologics, Inc. (SYN) Reports First Quarter 2013 Financial Results
5/15/2013 7:10:14 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ROCKVILLE, Md., May 15, 2013 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of biologics focused on the prevention and treatment of serious infectious diseases, today reported financial results for the three months ended March 31, 2013 and summarized operational highlights.
Help employers find you! Check out all the jobs and post your resume.